Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04274413

CFTR Related Pancreatitis Study

Assessing CFTR Function in Patients With CFTR Related Pancreatitis Using a Novel Sweat Test

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
The Hospital for Sick Children · Academic / Other
Sex
All
Age
4 Years
Healthy volunteers
Not accepted

Summary

The main causes of acute recurrent pancreatitis (ARP) or chronic pancreatitis (CP) in children are defects in genes that have been associated to pancreatitis. Among these gene defects CFTR gene mutations are commonly found, 34% ARP and 23% CP . Since not every CFTR gene mutations clinically manifest, just identifying these CFTR gene mutations may not help to establish a clear role of this defect in the etiology of the individual ARP/CP. The novel beta-adrenergic sweat secretion test is a very sensitive test to detect small abnormalities in CFTR function in form of a linear gene-function relation. By identifying even mild CFTR defects, in future will help in finding the role of CFTR modulators and providing treatment to these patients.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTBeta Adrenergic Sweat TestIn Beta Sweat Test - sweat secretion will be stimulated by injecting a series of drugs within the skin surface. Small needles will be used to inject minute amounts of each drug. Before and after each skin injection, the skin will be cleaned using an alcohol swab. 1. Two sensor probes will be strapped to the forearm with rubber bands in position just above the injection site. 2. Under the first probe, injection atropine will be given in one small area of the skin. 3. Under the second probe, first injection carbachol will be given in one small area of the skin. 4. Next, at the second probe area, the normal sweating will be stopped for awhile by injecting a drug called atropine. 5. Lastly, beta-adrenergic sweating will be stimulated by injecting a combination of the following drugs: atropine, isoproterenol, and aminophylline (β-cocktail). Using probes, all sweat rate readings will be recorded.

Timeline

Start date
2021-02-01
Primary completion
2021-02-01
Completion
2021-02-01
First posted
2020-02-18
Last updated
2021-07-16

Source: ClinicalTrials.gov record NCT04274413. Inclusion in this directory is not an endorsement.